All Rankings

Top 100 Cambridge Startups 2026

The most-funded startups headquartered in Cambridge, ranked by total capital raised.

Known total funding for 94 of 100 ranked companies: $6.9B.

Showing top 100 matching companies · Ranked by total funding raised

Use company data through the API.
Example request
curl "https://indexed.vc/api/v1/companies?countries=United+Kingdom&cities=Cambridge&operatingStatus=active&sort=total_funding_raised&order=desc&limit=100" -H "X-API-Key: YOUR_API_KEY"

The API can include out-of-scope company records; this core research list excludes them.

The API has no company type filter, so public companies can appear; this list counts private companies only.

The API cannot leave out companies whose latest round is a grant, private equity or debt financing; this list does.

Data from Indexed.vcUpdated

Methodology: up to 100 active companies matching this list's filters are ordered by disclosed total funding in USD. Companies whose latest round is one of: Grant, Private Equity, Debt Financing are excluded. Totals include recorded grants and other qualifying funding, not just equity. Open a company profile for its funding summary and available detail. How this data is built.

1
CuspAI

CuspAI is a frontier AI company pioneering the discovery of breakthrough materials to power human...

Cambridge, United Kingdom11–50Artificial Intelligence, Climate Tech
Series BTotal funding$1.2BJul 2026
2
CMR Surgical

CMR Surgical develops Versius Plus, a surgical robot engineered for versatility and adaptability ...

Cambridge, United Kingdom501–1000Healthcare, Robotics
Venture RoundTotal funding$1.2BApr 2025
3
CellCentric

CellCentric develops inobrodib, an oral small molecule inhibitor targeting p300 and CBP, to treat...

Cambridge, United Kingdom11–50Biotech, Healthcare
Series DTotal funding$340.0MMay 2026
4
Artios

Artios develops DNA damage response cancer medicines, advancing targeted therapies for solid tumo...

Cambridge, United Kingdom51–200Biotech
Series DTotal funding$301.2MNov 2025
5
bit.bio

Cambridge-based biotech using opti-ox cell programming technology to produce precision human cell...

Cambridge, United Kingdom51–200Biotech, Healthcare
Series DTotal funding$249.5MNov 2026
6
T Therapeutics

T-Therapeutics develops first-in-class TCR-based medicines for cancer and autoimmune disease usin...

Cambridge, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$225.0MNov 2026
7
Crescendo Biologics

Humabody VH domain biologics for cancer and immunity

Cambridge, United Kingdom11–50Biotech, Healthcare
Extension RoundTotal funding$215.4MJul 2023
8
Cerevance

Cerevance develops cell-type specific treatments for neurodegenerative, psychiatric, and CNS-cont...

Cambridge, United Kingdom51–200Biotech
Series CTotal funding$209.5MMay 2026
9
Nyobolt

Nyobolt develops integrated, ultra-fast charging battery technology for mission-critical industri...

Cambridge, United Kingdom51–200Energy Storage, Hardware
Series CTotal funding$160.5MMay 2026
10
Amadeus Capital Partners

Invests in technology companies across multiple sectors and funding stages

Cambridge, United Kingdom51–200Artificial Intelligence
Venture RoundTotal funding$140.0MFeb 2023
11
Mission Therapeutics

Mission Therapeutics develops small molecules that inhibit USP30 to promote mitophagy and improve...

Cambridge, United Kingdom11–50Biotech, Healthcare
Venture RoundTotal funding$130.6MOct 2025
12
Luminance

Luminance's Legal-Grade AI automates and augments every contract touchpoint for more than 1,000 o...

Cambridge, United Kingdom201–500Artificial Intelligence, Legal Tech
Series CTotal funding$125.0MFeb 2025
13
Riverlane

Riverlane builds quantum error correction tools and technology, including proprietary QEC chips a...

Cambridge, United Kingdom51–200Quantum Computing
Series CTotal funding$118.1MAug 2024
14
Microbiotica

Microbiome-based therapeutics and diagnostics

Cambridge, United Kingdom11–50Biotech, Healthcare
Series CTotal funding$116.2MOct 2026
15
Healx

AI-enabled biotech using generative AI to discover and develop treatments for rare diseases, adva...

Cambridge, United Kingdom51–200Artificial Intelligence, Biotech
Series CTotal funding$114.5MAug 2024
16
Owlstone Medical

Cambridge UK biotech developing Breath Biopsy platform for early disease detection using volatile...

Cambridge, United Kingdom51–200Healthcare, Diagnostics
Series ETotal funding$107.0MJan 2025
17
Lightcast Discovery

Lightcast Discovery develops a flexible platform that enables precise interrogation of single-cel...

Cambridge, United Kingdom11–50Biotech, Healthcare
Venture RoundTotal funding$97.1MApr 2026
18
Maxion Therapeutics

Biotech developing antibody-based KnotBody therapeutics targeting ion channels and GPCRs to treat...

Cambridge, United Kingdom11–50Life Sciences, Biotech
Series ATotal funding$88.0MMar 2025
19
Immutrin

Immutrin is a biotechnology company developing next-generation antibody therapy to deplete system...

Cambridge, United Kingdom1–10Biotech
Venture RoundTotal funding$87.0MMar 2026
20
Ieso Digital Health

Digital mental health company delivering online CBT therapy; rebranded as Mindler in August 2025 ...

Cambridge, United Kingdom51–200Healthcare, SaaS
Series BTotal funding$76.5MNov 2021
21
Constructive Bio

Constructive Bio expands the genetic code so cells can design, engineer, and manufacture proteins...

Cambridge, United Kingdom11–50Biotech
Series ATotal funding$73.0MSep 2024
22
Nu Quantum

Quantum communications technology company developing quantum networking infrastructure.

Cambridge, United Kingdom51–200Deep Tech, Quantum Computing
Series ATotal funding$72.4MDec 2025
23
Cyted

Cyted provides non-endoscopic diagnostics that combine minimally invasive cell collection with mo...

Cambridge, United Kingdom11–50Biotech, Healthcare
Series BTotal funding$71.8MAug 2025
24
Speechmatics

Deep learning and speech recognition experts

Cambridge, United Kingdom51–200Artificial Intelligence, Natural Language Processing
Series BTotal funding$70.0MJun 2022
25
Evonetix

Cambridge-based company developing a desktop DNA synthesis platform using a radically different a...

Cambridge, United Kingdom51–200Biotech
Extension RoundTotal funding$66.3MFeb 2023